Get started
666

INTECH BIOPHARM LTD

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

6461 chart


Full chart

6461 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.87 B‬TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.70TWD
Net income (FY)
‪−337.99 M‬TWD
Revenue (FY)
‪25.85 M‬TWD
Shares float
‪69.78 M‬
Beta (1Y)
0.54

Employees


Employees (FY)
82
Change (1Y)
−6 −6.82%
Revenue / Employee (1Y)
‪10.27 K‬TWD
Net income / Employee (1Y)
‪−134.26 K‬TWD

About INTECH BIOPHARM LTD


Sector
Health Technology
CEO
Wei Hsiu Wu
Headquarters
Taipei
Website
intechbiopharm.com
Founded
2010
ISIN
TW0006461007
FIGI
BBG006S3TQF4
Intech Biopharm Ltd. engages in the development of drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease. Its products include HFA metered dosage inhaler; respiratory drugs; and oncology drugs. The company was founded on October 28, 2010 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6461 is 28.10 TWD — it has decreased by −0.18% in the past 24 hours. Watch INTECH BIOPHARM LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange INTECH BIOPHARM LTD stocks are traded under the ticker 6461.
6461 stock has risen by 0.36% compared to the previous week, the month change is a −4.10% fall, over the last year INTECH BIOPHARM LTD has showed a 16.36% increase.
6461 reached its all-time high on Jul 15, 2014 with the price of 122.95 TWD, and its all-time low was 11.10 TWD and was reached on Mar 23, 2020. View more price dynamics on 6461 chart.
See other stocks reaching their highest and lowest prices.
6461 stock is 0.54% volatile and has beta coefficient of 0.54. Track INTECH BIOPHARM LTD stock price on the chart and check out the list of the most volatile stocks — is INTECH BIOPHARM LTD there?
Today INTECH BIOPHARM LTD has the market capitalization of ‪3.87 B‬, it has decreased by −1.40% over the last week.
Yes, you can track INTECH BIOPHARM LTD financials in yearly and quarterly reports right on TradingView.
INTECH BIOPHARM LTD is going to release the next earnings report on Nov 8, 2024. Keep track of upcoming events with our Earnings Calendar.
6461 net income for the last quarter is ‪−92.62 M‬ TWD, while the quarter before that showed ‪−74.90 M‬ TWD of net income which accounts for −23.66% change. Track more INTECH BIOPHARM LTD financial stats to get the full picture.
No, 6461 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has 82.00 employees. See our rating of the largest employees — is INTECH BIOPHARM LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTECH BIOPHARM LTD EBITDA is ‪−250.79 M‬ TWD, and current EBITDA margin is −917.04%. See more stats in INTECH BIOPHARM LTD financial statements.
Like other stocks, 6461 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTECH BIOPHARM LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTECH BIOPHARM LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTECH BIOPHARM LTD stock shows the sell signal. See more of INTECH BIOPHARM LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.